Cytek Biosciences
CTKB
$6.22
Share price
0.32%
Change (1 day)
-47.64%
Change (1 year)
Categories
Operating Margin for Cytek Biosciences (CTKB)
Operating Margin as of May 2024 (TTM): 2.33%
According to Cytek Biosciences's latest financial reports and stock price the company's current Operating Margin is 2.33%. At the end of 2021 the company had an Operating Margin of 4.64%.
Operating Margin history for Cytek Biosciences from 2020 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 4.64% | -70.14% |
| 2020 | 15.54% | -155.22% |
| 2019 | -28.15% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.